---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295829006.md"
description: "On Thursday, several healthcare stocks experienced significant intraday volatility. Gainers included Liminatus Pharma (+48.4%), BeyondSpring (+26.7%), and Omeros (+23.6%), with some moves linked to Q2 earnings releases. Conversely, losers featured Valion Bio (-23.7%), Obsidian Therapeutics (-21.4%), and Outlook Therapeutics (-21.2%). The session highlighted sharp price swings among small-cap biotech firms."
datetime: "2026-08-13T17:05:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295829006.md)
  - [en](https://longbridge.com/en/news/295829006.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295829006.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Liminatus Pharma** (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million.
-   **BeyondSpring** (NASDAQ:BYSI) shares moved upwards by 26.67% to $0.94. The company's market cap stands at $30.5 million.
-   **Healthcare Triangle** (NASDAQ:HCTI) shares moved upwards by 25.0% to $1.55. The market value of their outstanding shares is at $2.5 million.
-   **Lexaria Bioscience** (NASDAQ:LEXX) shares increased by 24.67% to $7.63. The market value of their outstanding shares is at $10.1 million.
-   **LENSAR** (NASDAQ:LNSR) stock moved upwards by 24.0% to $7.8. The market value of their outstanding shares is at $77.2 million. As per the press release, Q2 earnings came out today.
-   **Omeros** (NASDAQ:OMER) shares moved upwards by 23.55% to $16.94. The market value of their outstanding shares is at $992.2 million. The company's, Q2 earnings came out yesterday.

### Losers

-   **Valion Bio** (NASDAQ:VBIO) stock fell 23.7% to $0.17 during Thursday's regular session.
-   **Obsidian Therapeutics** (NASDAQ:OBX) stock decreased by 21.42% to $22.0. The market value of their outstanding shares is at $1.7 billion.
-   **Outlook Therapeutics** (NASDAQ:OTLK) shares declined by 21.17% to $0.87. The market value of their outstanding shares is at $205.6 million.
-   **bioAffinity Technologies** (NASDAQ:BIAF) stock decreased by 19.62% to $0.38. The company's market cap stands at $2.9 million. As per the press release, Q2 earnings came out 4 days ago.
-   **BioStem Technologies** (NASDAQ:BSEM) shares decreased by 16.45% to $3.18. The market value of their outstanding shares is at $67.7 million. As per the press release, Q2 earnings came out yesterday.
-   **Ensysce Biosciences** (NASDAQ:ENSC) shares fell 14.68% to $0.34. The market value of their outstanding shares is at $6.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md)
- [OMER.US](https://longbridge.com/en/quote/OMER.US.md)
- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md)
- [OBX.US](https://longbridge.com/en/quote/OBX.US.md)
- [HCTI.US](https://longbridge.com/en/quote/HCTI.US.md)
- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [LNSR.US](https://longbridge.com/en/quote/LNSR.US.md)
- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)
- [BSEM.US](https://longbridge.com/en/quote/BSEM.US.md)
- [ENSC.US](https://longbridge.com/en/quote/ENSC.US.md)
- [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)
- [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md)
- [ENSCW.US](https://longbridge.com/en/quote/ENSCW.US.md)

## Related News & Research

- [Omeros director Joseph L. Schocken files initial beneficial ownership statement](https://longbridge.com/en/news/296288452.md)
- [Outlook Therapeutics, Inc. 2026: Revenue $8.7K, EPS ($0.15) — 10-Q Summary](https://longbridge.com/en/news/296273184.md)
- [Bit Origin To Implement 1-For-5 Reverse Stock Split To Meet Nasdaq Requirements](https://longbridge.com/en/news/296359463.md)
- [Nextpower (NASDAQ:NXT) Director Sells $310,497.20 in Stock](https://longbridge.com/en/news/296836235.md)
- [Agios Pharmaceuticals (NASDAQ:AGIO) Upgraded at TD Cowen](https://longbridge.com/en/news/296901511.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**